Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Phase 2 Study of Adjuvant Radiotherapy Following Narrow‐Margin Hepatectomy in Patients With HCCChen, Bo ; Wu, Jian‐Xiong ; Cheng, Shu‐Hui ; Wang, Li‐Ming ; Rong, Wei‐Qi ; Wu, Fan ; Wang, Shu‐Lian ; Jin, Jing ; Liu, Yue‐Ping ; Song, Yong‐Wen ; Ren, Hua ; Fang, Hui ; Tang, Yuan ; Li, Ning ; Li, Ye‐Xiong ; Wang, Wei‐HuHepatology (Baltimore, Md.), 2021-11, Vol.74 (5), p.2595-2604 [Periódico revisado por pares]United States: Wiley Subscription Services, IncTexto completo disponível |
|
2 |
Material Type: Artigo
|
Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma: A Randomized Clinical TrialTang, Ling-Long ; Guo, Rui ; Zhang, Ning ; Deng, Bin ; Chen, Lei ; Cheng, Zhi-Bin ; Huang, Jing ; Hu, Wei-Han ; Huang, Shao Hui ; Luo, Wei-Jun ; Liang, Jin-Hui ; Zheng, Yu-Ming ; Zhang, Fan ; Mao, Yan-Ping ; Li, Wen-Fei ; Zhou, Guan-Qun ; Liu, Xu ; Chen, Yu-Pei ; Xu, Cheng ; Lin, Li ; Liu, Qing ; Du, Xiao-Jing ; Zhang, Yuan ; Sun, Ying ; Ma, JunJAMA : the journal of the American Medical Association, 2022-08, Vol.328 (8), p.728-736 [Periódico revisado por pares]United States: American Medical AssociationTexto completo disponível |
|
3 |
Material Type: Artigo
|
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 studyZhong, Wen-Zhao ; Wang, Qun ; Mao, Wei-Min ; Xu, Song-Tao ; Wu, Lin ; Shen, Yi ; Liu, Yong-Yu ; Chen, Chun ; Cheng, Ying ; Xu, Lin ; Wang, Jun ; Fei, Ke ; Li, Xiao-Fei ; Li, Jian ; Huang, Cheng ; Liu, Zhi-Dong ; Xu, Shun ; Chen, Ke-Neng ; Xu, Shi-Dong ; Liu, Lun-Xu ; Yu, Ping ; Wang, Bu-Hai ; Ma, Hai-Tao ; Yan, Hong-Hong ; Yang, Xue-Ning ; Zhou, Qing ; Wu, Yi-Long ; Wu, Yi-Long ; Wang, Qun ; Mao, Wei-Min ; Wu, Lin ; Shen, Yi ; Liu, Yong-Yu ; Chen, Chun ; Cheng, Ying ; Xu, Lin ; Wang, Jun ; Fei, Ke ; Li, Xiao-Fei ; Li, Jian ; Huang, Cheng ; Liu, Zhi-Dong ; Xu, Shun ; Chen, Ke-Neng ; Xu, Shi-Dong ; Liu, Lun-Xu ; Yu, Ping ; Wang, Bu-Hai ; Ma, Hai-Tao ; Wang, Si-Yu ; Hu, Jian ; Liu, Wei ; Li, Wei ; Shi, Jian-HuaThe lancet oncology, 2018-01, Vol.19 (1), p.139-148 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
4 |
Material Type: Artigo
|
Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trialXu, Binghe ; Zhang, Qingyuan ; Zhang, Pin ; Hu, Xichun ; Li, Wei ; Tong, Zhongsheng ; Sun, Tao ; Teng, Yuee ; Wu, Xinhong ; Ouyang, Quchang ; Yan, Xi ; Cheng, Jing ; Liu, Qiang ; Feng, Jifeng ; Wang, Xiaojia ; Yin, Yongmei ; Shi, Yanxia ; Pan, Yueyin ; Wang, Yongsheng ; Xie, Weimin ; Yan, Min ; Liu, Yunjiang ; Yan, Ping ; Wu, Fei ; Zhu, Xiaoyu ; Zou, JianjunNature medicine, 2021-11, Vol.27 (11), p.1904-1909 [Periódico revisado por pares]United States: Nature Publishing GroupTexto completo disponível |
|
5 |
Material Type: Artigo
|
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialZhang, Pin ; Zhang, Qingyuan ; Tong, Zhongsheng ; Sun, Tao ; Li, Wei ; Ouyang, Quchang ; Hu, Xichun ; Cheng, Ying ; Yan, Min ; Pan, Yueyin ; Teng, Yuee ; Yan, Xi ; Wang, Ying ; Xie, Weimin ; Zeng, Xiaohua ; Wang, Xiaojia ; Hu, Changlu ; Geng, Cuizhi ; Zhang, Hongwei ; Li, Wenxin ; Wu, Xinhong ; Zhong, Jincai ; Xu, Jingwei ; Shi, Yanxia ; Wei, Wenhua ; Bayaxi, Nayima ; Zhu, Xiaoyu ; Xu, BingheThe lancet oncology, 2023-06, Vol.24 (6), p.646-657 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
6 |
Material Type: Artigo
|
Effectiveness and safety of low‐dose apatinib in advanced gastric cancer: A real‐world studyDu, Yingying ; Cao, Qisheng ; Jiang, Congqiao ; Liang, Hui ; Ning, Zhongliang ; Ji, Chushu ; Wang, Jinguo ; Zhou, Chaoping ; Jiang, Zonghui ; Yu, Changjun ; Li, Lei ; Zhao, Yong ; Xu, Yuemei ; Xu, Tengyun ; Hu, Wenjun ; Wang, Daoqin ; Cheng, Huaidong ; Wang, Guihe ; Zhou, Jinhua ; Wang, Song ; Zhang, Yanshun ; Hu, Zhiqiang ; Li, Xinzhong ; Lu, Donghui ; Zhang, Jun ; Xie, Hua ; Sun, GuopingCancer medicine (Malden, MA), 2020-07, Vol.9 (14), p.5008-5014 [Periódico revisado por pares]United States: John Wiley & Sons, IncTexto completo disponível |
|
7 |
Material Type: Artigo
|
Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: Primary results from PALOMA-4Xu, Binghe ; Hu, Xichun ; Li, Wei ; Sun, Tao ; Shen, Kunwei ; Wang, Shusen ; Cheng, Ying ; Zhang, Qingyuan ; Cui, Shude ; Tong, Zhongsheng ; Geng, Cuizhi ; Song, Erwei ; Huang, Chiun-Sheng ; Sriuranpong, Virote ; Ngan, Roger K.C. ; Chia, Yee H. ; Wang, Xinwei ; Zhao, HuadongEuropean journal of cancer (1990), 2022-11, Vol.175, p.236-245 [Periódico revisado por pares]Oxford: Elsevier LtdTexto completo disponível |
|
8 |
Material Type: Artigo
|
Management of Complex Infections in Hemophagocytic Lymphohistiocytosis in AdultsZhang, Yi ; Cheng, Zhipeng ; Hu, Yu ; Tang, Liang VMicroorganisms (Basel), 2023-06, Vol.11 (7), p.1694 [Periódico revisado por pares]Switzerland: MDPI AGTexto completo disponível |
|
9 |
Material Type: Artigo
|
MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2– advanced breast cancer: the multinational randomized phase III studyZhang, Qing Yuan ; Sun, Tao ; Yin, Yong Mei ; Li, Hui Ping ; Yan, Min ; Tong, Zhong Sheng ; Oppermann, Christina P. ; Liu, Yun Peng ; Costa, Romulo ; Li, Man ; Cheng, Ying ; Ouyang, Qu Chang ; Chen, Xi ; Liao, Ning ; Wu, Xin Hong ; Wang, Xiao Jia ; Feng, Ji Feng ; Hegg, Roberto ; Kanakasetty, G.B. ; Coccia-Portugal, Maria A. ; Han, Ru Bing ; Lu, Yi ; Chi, Hai Dong ; Jiang, Ze Fei ; Hu, Xi ChunTherapeutic advances in medical oncology, 2020, Vol.12, p.1758835920963925-1758835920963925 [Periódico revisado por pares]London, England: SAGE PublicationsTexto completo disponível |
|
10 |
Material Type: Artigo
|
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trialLiu, Xu ; Zhang, Yuan ; Yang, Kun-Yu ; Zhang, Ning ; Jin, Feng ; Zou, Guo-Rong ; Zhu, Xiao-Dong ; Xie, Fang-Yun ; Liang, Xiao-Yu ; Li, Wen-Fei ; He, Zhen-Yu ; Chen, Nian-Yong ; Hu, Wei-Han ; Wu, Hai-Jun ; Shi, Mei ; Zhou, Guan-Qun ; Mao, Yan-Ping ; Guo, Rui ; Sun, Rui ; Huang, Jing ; Liang, Shao-Qiang ; Wu, Wei-Li ; Su, Zhen ; Li, Ling ; Ai, Ping ; He, Yu-Xiang ; Zang, Jian ; Chen, Lei ; Lin, Li ; Huang, Shao Hui ; Xu, Cheng ; Lv, Jia-Wei ; Li, Ying-Qing ; Hong, Shu-Bin ; Jie, Yu-Sheng ; Li, Hao ; Huang, Sai-Wei ; Liang, Ye-Lin ; Wang, Ya-Qin ; Peng, Ying-Lin ; Zhu, Jin-Han ; Zang, Sheng-Bing ; Liu, Song-Ran ; Lin, Qing-Guang ; Li, Hao-Jiang ; Tian, Li ; Liu, Li-Zhi ; Zhao, Hong-Yun ; Lin, Ai-Hua ; Li, Ji-Bin ; Liu, Na ; Tang, Ling-Long ; Chen, Yu-Pei ; Sun, Ying ; Ma, JunThe Lancet (British edition), 2024-06, Vol.403 (10445), p.2720-2731 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |